Anthralin or dithranol
- Level
- Commodity
- Parent
- 51241200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51241224This classification denotes an anti-psoriatic agent with the molecular formula C14H10O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8CJK0JH5M, chemically known as 1,8,9-anthracenetriol but generally known as anthralin, which bears US NIH Compound Identifier 2202. Anthralin most often comes in base and triacetate forms. European Medicines Agency schedules Dithranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06332MIG. The term DITHRANOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules anthralin in its Anatomical Therapeutic Chemical (ATC) Classification. Anthralin or dithranol bears US NLM identifiers UMLS ID C0003166 and NCI Concept Code C28827. SMILES: O=C1C2C(CC3C1C(O)CCC3)CCCC2O.
Same parent
Under 51241200 · 46Activities that produce or sell this
KBLI · 9Inherited from family 51240000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.